Stockreport

How The Regeneron (REGN) Story Is Shifting As Dupixent And Pipeline Expectations Reset [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Regeneron Pharmaceuticals is back in focus after a refreshed valuation framework lifted the modelled fair value estimate from US$821.12 to US$873.78 per share, a step u [Read more]